Last reviewed · How we verify
A Study to Describe the Persistence With Ozanimod Treatment in Relapsing-Remitting Multiple Sclerosis (RRMS) Participants (AppreZiate)
The purpose of the study is to collect clinical data on the persistence with ozanimod treatment, as well as to describe its effects on participant-relevant outcome parameters in treatment-naïve participants with RRMS.
Details
| Lead sponsor | Bristol-Myers Squibb |
|---|---|
| Status | ACTIVE_NOT_RECRUITING |
| Enrolment | 200 |
| Start date | Wed Jun 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Mon Nov 09 2026 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Relapsing-remitting Multiple Sclerosis (RRMS)
Countries
Spain